These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7260974)

  • 21. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal denervation significantly attenuates cardiorenal fibrosis in rats with sustained pressure overload.
    Liu Q; Lu D; Wang S; Wang K; Zhang Q; Wang Y; Fang P; Li Z; Geng J; Shan Q
    J Am Soc Hypertens; 2016 Jul; 10(7):587-596.e4. PubMed ID: 27288113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in angiotensin II and aldosterone secretion in patients with pressure overloaded systemic right ventricles are similar to those observed in systemic arterial hypertension.
    Szymański P; Klisiewicz A; Lubiszewska B; Lipczyńska M; Kowalski M; Janas J; Hoffman P
    Int J Cardiol; 2011 Mar; 147(3):366-70. PubMed ID: 19896738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of tanshinone II(A) on expression of different components in renin-angiotensin system of left ventricles of hypertensive rats].
    Yu LZ; Shi CR
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1468-72. PubMed ID: 25039184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system.
    Gammelgaard I; Wamberg S; Bie P
    Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
    van Kats JP; Sassen LM; Danser AH; Polak MP; Soei LK; Derkx FH; Schalekamp MA; Verdouw PD
    Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrepant effects of angiotensin II and phenylephrine on plasma volume in conscious goats.
    Olsson K; Hossaini-Hilali J; Cvek K
    Acta Physiol Scand; 1994 May; 151(1):83-90. PubMed ID: 8048338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing plasma renin and angiotensin II in the conscious pregnant ewe and its foetus.
    Broughton Pipkin F; Lumbers ER; Mott JC
    J Physiol; 1974 Dec; 243(3):619-36. PubMed ID: 4375185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predominant right ventricular infarction in malignant renovascular hypertension in rats.
    Fueyo A; Esteban MM; Marín B; Rojo-Ortega JM
    J Lab Clin Med; 1987 Jul; 110(1):106-12. PubMed ID: 3598333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphofunctional characteristics of myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of angiotensin II].
    Frolov VA; Drozdova GA; Mustiatsa VF; Balaev VV
    Dokl Akad Nauk; 1999 May; 366(3):413-5. PubMed ID: 10420261
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
    Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.
    Schunkert H; Ingelfinger JR; Jacob H; Jackson B; Bouyounes B; Dzau VJ
    Am J Physiol; 1992 Nov; 263(5 Pt 1):E863-9. PubMed ID: 1443118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged infusion of norepinephrine in the conscious dog: effects on blood pressure, heart rate, renin, angiotensin II, and aldosterone.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S114-21. PubMed ID: 6175823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
    Schenk S; McCarthy PM; Starling RC; Hoercher KJ; Hail MD; Ootaki Y; Francis GS; Doi K; Young JB; Fukamachi K
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):38-43. PubMed ID: 15224019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperglycaemia emerging during general anaesthesia induces rat acute kidney injury via impaired microcirculation, augmented apoptosis and inhibited cell proliferation.
    Efrati S; Berman S; Hamad RA; Siman-Tov Y; Chanimov M; Weissgarten J
    Nephrology (Carlton); 2012 Feb; 17(2):111-22. PubMed ID: 22066573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prorenin contributes to angiotensin peptide formation in transgenic rats with rat prorenin expression targeted to the liver.
    Campbell DJ; Karam H; Ménard J; Bruneval P; Mullins JJ
    Hypertension; 2009 Dec; 54(6):1248-53. PubMed ID: 19841286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary angiotensin II: a marker of renal tissue activity?
    Reams G; Villarreal D; Wu Z; Bauer JH
    Nephron; 1994; 67(4):450-8. PubMed ID: 7969680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.